You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Evgen completes three cohorts for SFX-01

Evgen Pharma – a company focused on the development of sulforaphane-based medicines – has announced that it has completed the dosing of all three cohorts of its dose-escalating, placebo-controlled, randomised phase 1/1b clinical trial.